Paul Wotton

(Dr. Paul Wotton Ph.D.)

Currently holds positions in Cynata Therapeutics Ltd and Vericel Corp

Positions

Position Company Period
Chairman of the Board Cynata Therapeutics Ltd Feb. 28, 2017 -
Independent Director Vericel Corp Jan. 1, 2017 -
Director Vericel Corp Jan. 7, 2015 - Jan. 1, 2017
President, Chief Executive Officer, Director Ocata Therapeutics Inc July 31, 2014 - Feb. 10, 2016
President, Chief Executive Officer Ocata Therapeutics Inc July 21, 2014 - July 31, 2014
President, Chief Executive Officer, Director Antares Pharma Inc Oct. 10, 2008 - June 23, 2014
Paul Wotton's trades of Vericel Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-05 2024-12-04
US Vericel Corp (VCEL)
S Sale
2,600 -8.7%
58.72
USD 152,672 		2,600 -8.7% 58.72 USD 152,672
2023-12-15 2023-12-14
US Vericel Corp (VCEL)
S Sale
5,000 -15.7%
37.31
USD 186,550 		5,000 -15.7% 37.31 USD 186,550
2021-05-17 2021-05-14
US Vericel Corp (VCEL)
S Sale
5,000 -15.8%
50.52
USD 252,611 		5,000 -15.8% 50.52 USD 252,611
2021-05-13 2021-05-12
US Vericel Corp (VCEL)
S Sale
2,200 -6.5%
48.88
USD 107,534 		2,200 -6.5% 48.88 USD 107,534
2021-05-13 2021-05-11
US Vericel Corp (VCEL)
S Sale
13,448 -28.5%
50.11
USD 673,922 		13,448 -28.5% 50.11 USD 673,922
2019-01-04 2019-01-02
US Vericel Corp (VCEL)
PS Planned sale
17,500 -100.0%
16.83
USD 294,539 		17,500 -100.0% 16.83 USD 294,539
2019-01-04 2019-01-02
US Vericel Corp (VCEL)
PS Planned sale
5,000 -100.0%
16.83
USD 84,154 		5,000 -100.0% 16.83 USD 84,154
// ... existing code ... // ... rest of the file ...